ArticleBasic research in cardiology2026

Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion.

Carmine Rocca et al.PubMed ↗Publisher ↗

No numbers read from the abstract.